Marijuana Data Collection Act [HB-3043]
[Cannabis ]
[Healthcare ]
[Science ]
[Public Health ]
To direct the Secretary of Health and Human Services to enter into a 10-year arrangement with the National Academy of Sciences to conduct and update biennially a study on the effects of State legalized marijuana programs, and for other purposes.
HB-3043: Marijuana Data Collection Act
Sponsored by: Rep. Don Young
Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 11/09/2021
Drug Price Transparency Act of 2021 [S.1523]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Medicare and Medicaid ]
A bill to amend title XI of the Social Security Act and title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits.
S.1523: Drug Price Transparency Act of 2021
Sponsored by: Sen. Roger Marshall
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/29/2021
Marijuana Data Collection Act [S.1456]
[Cannabis ]
[Healthcare ]
[Science ]
[Public Health ]
A bill to direct the Secretary of Health and Human Services to enter into a 10-year arrangement with the National Academy of Sciences to conduct and update biennially a study on the effects of State legalized marijuana programs, and for other purposes.
S.1456: Marijuana Data Collection Act
Sponsored by: Sen. Robert Menendez
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/29/2021
Changing the Culture of the FDA Act [S.1436]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
A bill to direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration.
S.1436: Changing the Culture of the FDA Act
Sponsored by: Sen. Joe Manchin
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/28/2021
FDA Accountability for Public Safety Act [S.1439]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
[Overdose Prevention ]
[Public Safety ]
A bill to establish procedures regarding the approval of opioid drugs by the Food and Drug Administration.
S.1439: FDA Accountability for Public Safety Act
Sponsored by: Sen. Angus King
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 04/28/2021
Increasing Access to Biosimilars Act of 2021 [S.1427]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
A bill to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.
S.1427: Increasing Access to Biosimilars Act of 2021
Sponsored by: Sen. John Cornyn
Read Twice And Referred To The Committee On Finance. on 04/28/2021
Increasing Access to Biosimilars Act of 2021 [HB-2869]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Senior Citizens ]
To require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.
HB-2869: Increasing Access to Biosimilars Act of 2021
Sponsored by: Rep. Tony Cardenas
Referred To The Subcommittee On Health. on 04/29/2021
Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act [HB-2884]
[Healthcare ]
[Pharmaceuticals ]
[Consumer Protection ]
To amend title 35, United States Code, to clarify and improve the process for subsection (k) applicants to resolve patent infringement claims for biological products (commonly known as the "patent dance"), and for other purposes.
HB-2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
Sponsored by: Rep. Henry Johnson
Committee Consideration And Mark-up Session Held. on 09/30/2021
Preserve Access to Affordable Generics and Biosimilars Act [HB-2891]
[Pharmaceuticals ]
[Healthcare ]
[Consumer Protection ]
To prohibit prescription drug companies from compensating other prescription drug companies to delay the entry of a generic drug, biosimilar biological product, or interchangeable biological product into the market.
HB-2891: Preserve Access to Affordable Generics and Biosimilars Act
Sponsored by: Rep. David Cicilline
Committee Consideration And Mark-up Session Held. on 09/29/2021
S.1435: Affordable Prescriptions for Patients Act of 2021
Sponsored by: Sen. Chuck Grassley
Committee On The Judiciary. Ordered To Be Reported With An Amendment In The Nature Of A Substitute Favorably. on 07/29/2021
Medicare Buy-In and Health Care Stabilization Act of 2021 [HB-2881]
[Healthcare ]
[Medicare and Medicaid ]
[Insurance ]
[Public Health ]
[Senior Citizens ]
To amend title XVIII of the Social Security Act to provide for an option for individuals who are ages 50 to 64 to buy into Medicare, to provide for health insurance market stabilization, and for other purposes.
HB-2881: Medicare Buy-In and Health Care Stabilization Act of 2021
Sponsored by: Rep. Tim Ryan
Referred To The Subcommittee On Health. on 04/29/2021
Stop Stalling Access to Affordable Medications [HB-2883]
[Healthcare ]
[Pharmaceuticals ]
[Consumer Protection ]
[Public Health ]
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.
HB-2883: Stop Stalling Access to Affordable Medications
Sponsored by: Rep. David Cicilline
Committee Consideration And Mark-up Session Held. on 09/29/2021